By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Senzime AB (publ)

Senzime AB (publ) (SNZZF)

OTC Market Data in USD, Fundamentals in SEK
$0.71
$0.00
0.00%
Last Update: 2 Sept 2025, 00:00
$110.87M
Market Cap
-6.88
P/E Ratio (TTM)
Forward Dividend Yield
$0.39 - $0.80
52 Week Range

SNZZF Stock Price Chart

Explore Senzime AB (publ) interactive price chart. Choose custom timeframes to analyze SNZZF price movements and trends.

SNZZF Company Profile

Discover essential business fundamentals and corporate details for Senzime AB (publ) (SNZZF) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

31 Jan 2017

Employees

54.00

CEO

Philip Siberg

Description

Senzime AB (publ), a medical device company, develops and markets patient monitoring systems to monitor patients under anesthesia in Europe, Oceania, Asia, Canada, and the United States. The company offers TetraGraph, a monitor that stimulates, measures, analyzes, and displays muscle function in surgical patients receiving neuromuscular blocking agents; TetraSens electrode array, which has two proximal stimulating electrodes for recording and reference; TetraConnect, a data management portal that helps clinician to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and Onzurf Probe, a sterile CE-marked single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.

SNZZF Financial Timeline

Browse a chronological timeline of Senzime AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 20 Apr 2026

Upcoming earnings on 16 Feb 2026

Upcoming earnings on 4 Nov 2025

Earnings released on 18 Jul 2025

EPS came in at -$0.03 falling short of the estimated -$0.02 by -42.62%, while revenue for the quarter reached $2.68M , beating expectations by +2.50%.

Earnings released on 22 Apr 2025

EPS came in at -$0.03 falling short of the estimated -$0.02 by -9.20%, while revenue for the quarter reached $2.35M , missing expectations by -90.42%.

Earnings released on 17 Feb 2025

EPS came in at -$0.02 falling short of the estimated -$0.02 by -0.17%, while revenue for the quarter reached $1.26M , missing expectations by -22.03%.

Earnings released on 6 Nov 2024

EPS came in at -$0.03 falling short of the estimated -$0.02 by -11.85%, while revenue for the quarter reached $1.68M , missing expectations by -3.28%.

Earnings released on 26 Aug 2024

EPS came in at -$0.03 falling short of the estimated -$0.02 by -40.63%, while revenue for the quarter reached $1.41M , missing expectations by -10.54%.

Earnings released on 7 May 2024

EPS came in at -$0.02 surpassing the estimated -$0.03 by +23.23%, while revenue for the quarter reached $1.12M , missing expectations by -11.38%.

Earnings released on 15 Feb 2024

EPS came in at -$0.03 falling short of the estimated -$0.03 by -8.88%, while revenue for the quarter reached $1.07M , missing expectations by -15.05%.

Earnings released on 30 Sept 2023

EPS came in at -$0.03 falling short of the estimated -$0.03 by -9.32%, while revenue for the quarter reached $830.98K , missing expectations by -15.63%.

Earnings released on 30 Jun 2023

EPS came in at -$0.04 falling short of the estimated -$0.03 by -25.94%, while revenue for the quarter reached $779.90K , beating expectations by +19.01%.

Stock split effective on 22 Jun 2023

Shares were split 1013 : 1000 , changing the number of shares outstanding and the price per share accordingly.

Earnings released on 31 Mar 2023

EPS came in at -$0.04 , while revenue for the quarter reached $700.24K , beating expectations by +30.39%.

Earnings released on 1 Feb 2023

EPS came in at -$0.03 , while revenue for the quarter reached $444.29K .

Earnings released on 10 Nov 2022

EPS came in at -$0.07 , while revenue for the quarter reached $332.00K .

Earnings released on 15 Jul 2022

EPS came in at -$0.06 , while revenue for the quarter reached $330.79K .

Earnings released on 5 May 2022

EPS came in at -$0.03 , while revenue for the quarter reached $251.64K .

Earnings released on 17 Feb 2022

EPS came in at -$0.04 , while revenue for the quarter reached $409.72K .

Earnings released on 12 Nov 2021

EPS came in at -$0.03 , while revenue for the quarter reached $163.54K .

Earnings released on 27 Aug 2021

EPS came in at -$0.04 , while revenue for the quarter reached $511.68K .

Earnings released on 6 May 2021

EPS came in at -$0.03 , while revenue for the quarter reached $164.33K .

Earnings released on 26 Feb 2021

EPS came in at -$0.03 , while revenue for the quarter reached $424.08K .

Earnings released on 6 Nov 2020

EPS came in at -$0.02 , while revenue for the quarter reached $234.21K .

SNZZF Stock Performance

Access detailed SNZZF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run